Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03901014 · ClinicalTrials.gov registry record · NA
Investigating the Production of Lipoproteins and Acetyl-CoA During a Ketogenic Diet
A NA study of Cholesterol Metabolism and Ketone Metabolism, sponsored by Touro University, California.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT03901014: Completed NA study of Cholesterol Metabolism and Ketone Metabolism, sponsored by Touro University, California.
NCT03901014 is a NA study of Cholesterol Metabolism and Ketone Metabolism that has completed, run by Touro University, California. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03901014, a NA study of Cholesterol Metabolism and Ketone Metabolism, has completed, sponsored by Touro University, California.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand how the reduction in dietary carbohydrates in a very-low carbohydrate ketogenic diet impacts the synthesis of cholesterol, fatty acid, and ketones, and the turnover rate of VLDL and chylomicron particles.
Primary Outcome
Change in serum total cholesterol between Day 3-7 (average value) to Day 17-21 (average value)
Conditions Studied
Interventions
- OTHER Very low carbohydrate diet
- OTHER Standard American diet
Study Locations (1)
California
- Touro University California - Vallejo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-03-31 |
| Est. Completion | 2019-04-18 |
| Phase | NA |
What the finished NCT03901014 record still lists
NCT03901014 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Cholesterol Metabolism appearing as the primary indexed condition, and to 2 interventions - of which Very low carbohydrate diet is the first listed.
NCT03901014 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03901014 about?
NCT03901014 is a clinical study titled "Investigating the Production of Lipoproteins and Acetyl-CoA During a Ketogenic Diet". The purpose of this study is to understand how the reduction in dietary carbohydrates in a very-low carbohydrate ketogenic diet impacts the synthesis of cholesterol, fatty acid, and ketones, and the turnover rate of VLDL and chylomicron particles.
What is the current status of trial NCT03901014?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2019-03-31. Estimated completion is 2019-04-18.
What conditions does trial NCT03901014 study?
This clinical trial studies the following conditions: Cholesterol Metabolism, Ketone Metabolism.
What interventions are being tested in trial NCT03901014?
The interventions under investigation include: Very low carbohydrate diet (OTHER), Standard American diet (OTHER).
Who is sponsoring clinical trial NCT03901014?
This trial is sponsored by Touro University, California, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03901014 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cholesterol Metabolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03901014's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI